Physicians' Academy for Cardiovascular Education

Post-ACS patients are not adequately treated with high-potency statin regimens

Predictors of Non use of a High-Potency Statin After an Acute Coronary Syndrome: Insights From the Stabilization of Plaques Using Darapladib-Thrombolysis in Myocardial Infarction 52 (SOLID-TIMI 52) Trial

Literature - Eisen A, Cannon CP, Braunwald E, et al. - J Am Heart Assoc. 2017;6:e004332

Main results

Conclusion

In a large, multinational, post-ACS population, most patients were not treated with high-potency statin regimens early and late after the event, including many patients at the highest risk of recurrent CV events. These findings emphasize the need of a better adherence to ACS guideline recommendations.

References

Show references

Find this article online at JAHA

Share this page with your colleagues and friends: